Ethical Issues on Pregnancy Termination: Impact of New Imaging ModalitiesGorincour G.a, b · Tassy S.a · Siméoni U.c · Le Coz P.a
aMediterranean Ethical Forum, EA 3783, Université de la Méditerranée, bMultidisciplinary Center for Prenatal Diagnosis, La Timone Hospital, and cDivision of Neonatology, La Conception Hospital, Marseille, France
Dr. Guillaume Gorincour
Mediterranean Ethical Forum, EA 3783
Université de la Méditerranée, La Timone Hospital
264, rue Saint-Pierre, FR–13385 Marseille (France)
Tel. +33 4 9138 6797, E-Mail Guillaume.GORINCOUR@ap-hm.fr
Do you have an account?
Objective: To explicate the ontological statuses of both the fetus and neonate as a basis for clinical ethical judgments about the obligations of both physicians and pregnant women to protect the life and health of both the fetus and the neonate. Methods: Despite drastic changes in perinatology, there is still a legal separation between fetuses and neonates. Neonatal status remains specific because of the prohibition of ‘transgressing human life’. Nevertheless, the concept of a ‘prenatal human being’ recently emerged. While new technologies blur the fetus/neonate borderline, why is it still legal in many European countries to terminate a fetal life in the late stages of pregnancy? One might even support the idea that what is authorized before birth should also be after, thereby ‘fetalizing’ neonates. Results: The ‘personalistic’ approach is against this ‘fetalization’, considering that terminating a neonate life is ‘transgressive’. The ‘utilitarian’ model considers we cannot decide what is good for someone else, which justifies terminating the life of neonates who are not persons yet. A phenomenological view supports the ontological difference on our perceptions, differing whether we observe ultrasound fetal images or real neonatal pictures. Conclusion: This does not mean the weight of fetal images should be underestimated.
© 2011 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.